The Canadian Breast Cancer Symposium returns as a one-day digital event on June 18 with a variety of engaging sessions that aim to foster a multidisciplinary, personalized approach to breast cancer management.
The symposium provides a comprehensive review of the many facets of breast cancer, while facilitating communication and collaboration among those treating breast cancer in Canada. State-of-the-art information will help optimize care for patients with breast cancer, including etiology, prevention, diagnosis, experimental biology and therapy of breast cancer and pre-malignant breast disease.
Some of this year’s topics include:
- Can we cure oligometastatic disease – Are we there yet?
- Multi-gene signatures and oncogenomics
- Neoadjuvant systemic therapy: Who should be offered this? Indications and controversies for neoadjuvant therapy (NAT)
- Breast Cancer in the younger and older populations
Participants can engage with speakers through online Q&A and submit further questions and comments through the digital platform’s tools. High-quality clinically relevant research from across Canada will also be presented as part of the Breast Cancer Research Forum.
Surgeons, oncologists, nurses, pathologists, residents, fellows and others involved in breast cancer treatment are encouraged to attend.For more information and to register, visit breastsymposium.ca